CAS: 78755-81-4; Ethyl 8-Fluoro-5-Methyl-6-Oxo-5,6-Dihydro-4H-Benzo[f]Imidazo[1,5-A][1,4]Diazepine-3-Carboxylate

该化合物是一种苯并二氮杂卓衍生物,主要以其作为苯并二氮杂卓受体的竞争对手的作用而闻名,在临床环境中经常使用,以扭转苯并二氮杂卓过量或镇静剂的影响,其特征是能够将苯并二氮杂卓从加巴-A受体的装配场所移走,从而抵消其镇静作用.氟硝化物通常静脉注射,其半衰期相对较短,这就需要仔细监测,在过量的情况下可能反复使用.其化学结构包括1,3-苯并二氮杂卓核核心,有助于其药性.虽然它有效扭转了镇静剂的生长,但氟共氮可导致依赖苯并二氮杂卓除酶的人产生排出症状,因此可能无法有效防治所有类型的镇静剂.此外,具有缉获历史的病人或已经服用过某些药物的人,如三环环共振动药物的并发症,如三苯并氏抗药的并发症等,其最终是关键工具.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号428507-28-2 (E)-(dimethylam... | CAS号193693-31-1 2-chloro-7-fluo... | CAS号999-97-3 六甲基二硅氮烷 | CAS号99-97-8 N,N-二甲基对甲苯胺 | CAS号3400-09-7 二氯胺 | CAS号2999-46-4 异氰基乙酸乙酯 | CAS号865-47-4 叔丁醇钾 | CAS号78755-80-3 7-氟-3.4-二氢-4-甲基... | CAS号658075-93-5 8-amino-5,6-dih... | CAS号133368-73-7 3'-fluoropropyl... | CAS号84378-44-9 Ro15-3890游离态

合成工艺路线路线简述

    5-甲基-8-硝基-6-氧代-5,6-二氢-4H-苯并[f]咪唑并[1,5-A][1,4]二氮杂卓-3-羧酸乙酯置于palladium On Activated Charcoal 亚硝酸特丁酯,三氟化硼乙醚,氢气体系中,用 四氢呋喃,乙醇,二氯甲烷 作为反应溶剂,化学反应 2.67H,反应生成 氟马西尼
    参考文献:一种适用于 Fluorine-18 标记的氟腙新合成方法
    标题:一种适用于 Fluorine-18 标记的氟腙新合成方法
    摘要:近年来,由于多种因素的共同作用,氟化有机化合物在生物医学领域越来越重要,例如 (I) 碳-氟键的稳定性,特别是在热和氧化降解方面 (II)氟和氢原子的类似空间要求允许类似的代谢途径和(iii)增强的亲脂性,与相应的氢化类似物相比,导致氟化化合物扩散到动物组织中.此外,"*f 标记的底物在正电子发射断层扫描 (Pet) 中充当示踪剂,这构成了体内药代动力学研究和非侵入性临床诊断的有用工具.*然而,由于半衰期(110 分钟)) 的氟 18 核素,只要在合成序列的最后一步掺入氟原子,就可以实现和操纵 18F 标记的底物.不幸的是,在大多数有机氟衍生物的合成中情况并非如此.在与药理学家合作计划的背景下,我们希望获得抗抑郁药氟马西尼 73 及其三唑类似物 10 的新条目,适用于最终的氟
    DOI:10.1080/00304940309355361

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-2012189547-A1
    优先权日:2009-10-08
    标 题 :[18f] labelled analogues of flumazenil as in vivo imaging agents
    发明人:WOODCRAFT JOHN; JONES CLARE L; GAETA ALESSANDRA; TRIGG WILLIAM JOHN; JONES PAUL ALEXANDER; PLANT STUART
    权利人:WOODCRAFT JOHN; JONES CLARE L; GAETA ALESSANDRA; TRIGG WILLIAM JOHN; JONES PAUL ALEXANDER; PLANT STUART
    摘要:The present invention provides radiofluorinated compounds useful for in vivo imaging GABA A receptors. Also provided by the present invention is a method of synthesis for the radiofluorinated compounds of the invention, in particular an automated method of synthesis. A further aspect of the invention is a cassette suitable for carrying out the automated method of synthesis of the invention.

    专利号:US-2022233673-A1
    优先权日:2019-06-04
    标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
    发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
    权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
    摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

    专利号:US-2005232861-A1
    优先权日:2004-04-20
    标 题 :Microfluidic apparatus and method for synthesis of molecular imaging probes including FDG
    发明人:BUCHANAN CHARLES R; PADGETT HENRY C; COLLIER THOMAS L
    权利人:BUCHANAN CHARLES R; PADGETT HENRY C; COLLIER THOMAS L
    摘要:The invention provides a method and apparatus for preparation of radiochemicals wherein the reaction that couples the radioactive isotope to the reactive precursor to form a positron-emitting molecular imaging probe is performed in a microfluidic environment. The method comprises: providing a micro reactor; introducing a liquid reactive precursor dissolved in a polar aprotic solvent into an inlet port of the micro reactor, the reactive precursor adapted for reaction with a radioactive isotope to form a radiochemical; introducing a solution comprising a radioactive isotope dissolved in a polar aprotic solvent into another inlet port of the micro reactor; contacting the reactive precursor with the isotope-containing solution in a microchannel of the micro reactor; reacting the reactive precursor with the isotope-containing solution as the reactive precursor and isotope-containing solution flow through the microchannel of the micro reactor, wherein the reacting step is conducted at a temperature above the boiling point of the polar aprotic solvent at 1 atm and at a pressure sufficient to maintain the polar aprotic solvent in liquid form; and collecting the resulting radiochemical from the micro reactor.

    专利号:WO-9964032-A1
    优先权日:1998-06-08
    标题 :Combinatorial synthesis of multibinding libraries
    发明人:CHRISTENSEN BURTON G; GRIFFIN JOHN H; JENKINS THOMAS E; JUDICE J KEVIN
    权利人:ADVANCED MEDICINE INC; CHRISTENSEN BURTON G; GRIFFIN JOHN H; JENKINS THOMAS E; JUDICE J KEVIN
    摘要:Disclosed are methods for synthesizing large collections of diverse multimeric compounds as well as iterative processes for evaluating key molecular constraints imparting multibinding properties to multimeric compounds. Also disclosed are libraries of multimeric compounds which can be evaluated for imparting multibinding properties.

    专利号:US-8895727-B2
    优先权日:2011-05-25
    标题 :Method for preparation of fluorine-18-labeled flumazenil using diaryliodonium salt precursor
    发明人:LEE BYUNG CHUL; MOON BYUNG SEOK; KIM JI SUN
    权利人:BIO IMAGING KOREA CO LTD
    摘要:Disclosed is the synthesis of [ 18 F]flumazenil that is useful in imaging epileptic lesions by PET (positron emission tomography). A method for preparing [ 18 F]flumazenil by reacting a diaryliodonium salt precursor with the positron-emitting radionuclide fluorine-18. [ 18 F]flumazenil can be prepared from the diaryliodonium salt precursor in the presence of kryptofix 2.2.2. /potassium carbonate(K 2.2.2. /K 2 CO 3 ) and TEMPO in dimethylformamide (DMF) at a high yield.
    烟台市蓬莱区融欣化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.qianweichem.com
    企业联系电话:0535-5602651,5602652;13963817008👤
    📞烟台市蓬莱区融欣化工有限公司 ⚠️参考联系方式
    联系人:陈总经理
    电话:0535-5602651,5602652;13963817008
    手机:13963817008
    传真:0535-5602653
    邮箱:sales@qianweichem.com
    通信地址: 山东省蓬莱市北沟镇蓬莱化工产业园
    邮编: 265600
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东省蓬莱市北沟镇蓬莱化工产业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    浙江仙琚制药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xjpharma.com
    电话: 0576-87772810👤
    📞浙江仙琚制药股份有限公司 ⚠️参考联系方式

    销售电话:0576-87772810
    邮箱:online@xjpharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海泽涵生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zehanbiopharma.com
    电话: 021-61350663 13052117465👤
    📞上海泽涵生物医药科技有限公司 ⚠️参考联系方式

    销售电话:021-61350663 13052117465
    邮箱:sales@zehanbiopharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    宁波市通途生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.torchbio.com
    企业联系电话:0574-27785925👤
    📞宁波市通途生物医药科技有限公司 ⚠️参考联系方式
    联系人:童总
    电话:0574-27785925
    手机:13805868231
    传真:0574-27785930
    邮箱:tgm@torchbio.com
    通信地址: 浙江省宁波市高新区江南路1558号浙大科创大楼1812室
    邮编: 315042
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省宁波市高新区江南路1558号浙大科创大楼1812室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication - A Systematic Review with Meta-Analyses of Randomised Trials. Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):37-44. doi: 10.1111/bcpt.12434. Epub 2015 Jul 28. Review. doi: 10.1016/bs.apha.2014.10.008. Epub 2014 Dec 30. Review. doi: 10.1111/bcp.12023. Review.
    5: Iseki K. [Flumazenil]. Chudoku Kenkyu. 2008 Oct;21(4):373-8. Review. Japanese. Review. Review. Review. Review. Review. Review. Review. Review. Review.
    15: Whitwam JG, Amrein R. Pharmacology of flumazenil. Acta Anaesthesiol Scand Suppl. 1995;108:3-14. Review. Review. Review. Review. Review. Review.

    合成参考文献


    参考文献:10.1007/s10928-005-0048-9
    摘要:Dokoumetzidis A, Aarons L. Propagation of Population Pharmacokinetic Information Using a Bayesian Approach: Comparison with Meta-Analysis. Journal of Pharmacokinetics and Pharmacodynamics. 2005 Aug;32(3-4):401–18. doi: 10.1007/s10928-005-0048-9.
    参考文献:10.1021/jm2001597
    摘要:Anzini M, Valenti S, Braile C, Cappelli A, Vomero S, Alcaro S, Ortuso F, Marinelli L, Limongelli V, Novellino E, Betti L, Giannaccini G, Lucacchini A, Daniele S, Martini C, Ghelardini C, Di Cesare Mannelli L, Giorgi G, Mascia MP, Biggio G. New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds. J. Med. Chem. 2011 Jul 27;54(16):5694–711. doi: 10.1021/jm2001597.
    参考文献:10.1016/j.jep.2011.07.003
    摘要:Costa CA, Kohn DO, de Lima VM, Gargano AC, Flório JC, Costa M. The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass). J Ethnopharmacol. 2011 Sep 01;137(1):828–36. doi: 10.1016/j.jep.2011.07.003.
    参考文献:10.1007/s00216-011-5187-9
    摘要:Remane D, Meyer MR, Wissenbach DK, Maurer HH. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Analytical and Bioanalytical Chemistry. 2011 Jul 21;401(4):1341. doi: 10.1007/s00216-011-5187-9.
    参考文献:10.3389/fphar.2011.00018
    摘要:Iyer SV, Benavides RA, Chandra D, Cook JM, Rallapalli S, June HL, Homanics GE. α4-Containing GABA(A) Receptors are Required for Antagonism of Ethanol-Induced Motor Incoordination and Hypnosis by the Imidazobenzodiazepine Ro15-4513. Front Pharmacol. 2011;2():18.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知